Nuwellis, Inc.

$0.99+1.19%(+$0.01)
TickerSpark Score
45/100
Weak
84
Valuation
40
Profitability
10
Growth
60
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUWE research report →

52-Week Range0% of range
Low $0.90
Current $0.99
High $41.58

Companywww.nuwellis.com

Nuwellis, Inc. , a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.

CEO
John L. Erb
IPO
2012
Employees
38
HQ
Eden Prairie, MN, US

Price Chart

-97.58% · this period
$40.14$20.55$0.97May 20Nov 18May 20

Valuation

Market Cap
$893.10K
P/E
-0.11
P/S
0.10
P/B
0.72
EV/EBITDA
0.08
Div Yield
0.00%

Profitability

Gross Margin
65.47%
Op Margin
-141.53%
Net Margin
-214.90%
ROE
-17015.80%
ROIC
-335.34%

Growth & Income

Revenue
$8.27M · -5.38%
Net Income
$-17,521,000 · -56.93%
EPS
$-25.39 · -217.38%
Op Income
$-11,106,000
FCF YoY
-12.94%

Performance & Tape

52W High
$41.58
52W Low
$0.90
50D MA
$1.12
200D MA
$2.62
Beta
0.25
Avg Volume
61.89K

Get TickerSpark's AI analysis on NUWE

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Apr 28, 26WALLER GREGORY Dother6,744
Apr 28, 26Emerson Martin Jother6,744
Apr 28, 26Feldshon Archelle Georgiouother6,744
Apr 28, 26McDonald Davidother6,744
Feb 24, 26Emerson Martin Jother0
Feb 24, 26McDonald Davidother7
Feb 24, 26McDonald Davidother416
Jan 28, 26Schultz Carisaother0
Jan 21, 26Field Katharynother0
Jan 21, 26Grasso Mikaother0

Our NUWE Coverage

We haven't published any research on NUWE yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate NUWE Report →

Similar Companies